Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative Atrial Fibrillation and Kidney Injury (STENOTYPE Trial)

NCT05852704 is registered in ClinicalTrials.gov with Region Örebro County as lead sponsor.

NCT NCT05852704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05852704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative Atrial Fibrillation and Kidney Injury (STENOTYPE Trial)
Lead sponsor
Region Örebro County
Phase
Phase 3
Overall status
Recruiting
Start date
April 4, 2024
Completion date
December 4, 2028
Enrollment
800 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, chronic coronary syndrome